VTI – Visioneering Technologies, Inc.
Visioneering Technologies is a medical device company that was incorporated in 2008 in the US State of Delaware. Its head office is based in the US State of Georgia. The Company’s principal activity is the design, manufacture, sale and distribution of its proprietary NaturalVue™ Multifocal 1 Day contact lenses for adults with Presbyopia (an age-related condition resulting in difficulty seeing near objects) and children with Myopia (difficulty seeing distant objects).
It is anticipated that VTI will list on the ASX during March 2017.
